JPRN-UMIN000007378已完成未知
Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents. - Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.
Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine0 个研究点目标入组 200 人开始时间: 2012年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patient who has glucagonoma
研究者
相似试验
招募中
不适用
Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID): a single-arm, multicenter, open-label,prospective exploratory trialtype 1 diabetesJPRN-UMIN000039635agasaki University Hospital24
进行中（未招募）
不适用
Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel
已完成
不适用
Effect of glucagon-like-peptide-1 (GLP-1) on left ventricular function during percutaneous coronary intervention (PCI)ISRCTN77442023Papworth Hospital NHS Foundation Trust (UK)40
已完成
不适用
Alternation in glucagon secretion associated with progression of glucose intolerance.normal glucose tolerance, impaired glucose metabolism, Type 2 diabetes mellitus (non-insulin dependent)JPRN-UMIN000016133Kitasato University School of Medicine53
招募中
不适用
Investigation of the secretion of glucagon for glucose intoleranceormal glucose tolerance (NGT), Impaired glucose tolerance(IGT), Type 2 diabetes (T2DM)JPRN-UMIN000019252Kobe university school of medicine, Diabetes and Endocrinoplogy105